1. Gormley M, Creaney G, Schache A, Ingarfield K, Conway DI. Reviewing the epidemiology of head and neck cancer: definitions, trends and risk factors. Br Dent J. 2022;233:780-6.

https://doi.org/10.1038/s41415-022-5166-x

PMid:36369568 PMCid:PMC9652141

2. Daroit NB, Martins LN, Garcia AB, Haas AN, Maito FLDM, Rados PV. Oral cancer over six decades: a multivariable analysis of a clinicopathologic retrospective study. Braz Dent J. 2023;34:115-24.

https://doi.org/10.1590/0103-6440202305264

PMid:38133466 PMCid:PMC10759960

3. Hussein AA, Helder MN, de Visscher JG, Leemans CR, Braakhuis BJ, Forouzanfar T. Global incidence of oral and oropharynx cancer in patients younger than 45 years versus older patients: A systematic review. Eur J Cancer. 2017;82:115-27.

https://doi.org/10.1016/j.ejca.2017.05.026

PMid:28654785 

4. van Monsjou HS, Wreesmann VB, van den Brekel MWM, Balm AJM. Head and neck squamous cell carcinoma in young patients. Oral Oncol. 2013;49:1097-102.

https://doi.org/10.1016/j.oraloncology.2013.09.001

PMid:24103389 

5. Toporcov TN, Znaor A, Zhang ZF, Yu GP, Winn DM, Wei Q, et al. Risk factors for head and neck cancer in young adults: a pooled analysis in the INHANCE consortium. Int J Epidemiol. 2015;44:169-85.

https://doi.org/10.1093/ije/dyu255

PMid:25613428 PMCid:PMC4339764

6. Llewellyn CD, Johnson NW, Warnakulasuriya KA. Risk factors for squamous cell carcinoma of the oral cavity in young people--a comprehensive literature review. Oral Oncol. 2001;37:401-18.

https://doi.org/10.1016/S1368-8375(00)00135-4

PMid:11377229 

7. Warnakulasuriya S, Kujan O, Aguirre-Urizar JM, Bagan JV, González-Moles MÁ, Kerr AR, et al. Oral potentially malignant disorders: A consensus report from an international seminar on nomenclature and classification, convened by the WHO Collaborating Centre for Oral Cancer. Oral Dis. 2021;27:1862-80.

https://doi.org/10.1111/odi.13704

PMid:33128420 

8. Aguirre-Urizar JM, Lafuente-Ibáñez de Mendoza I, Warnakulasuriya S. Malignant transformation of oral leukoplakia: Systematic review and meta-analysis of the last 5 years. Oral Dis. 2021;27:1881-95.

https://doi.org/10.1111/odi.13810

PMid:33606345 

9. Iocca O, Sollecito TP, Alawi F, Weinstein GS, Newman JG, De Virgilio A, et al. Potentially malignant disorders of the oral cavity and oral dysplasia: A systematic review and meta-analysis of malignant transformation rate by subtype. Head Neck. 2020;42:539-55.

https://doi.org/10.1002/hed.26006

PMid:31803979 

10. Mneimneh WS, Xu B, Ghossein C, Alzumaili B, Sethi S, Ganly I, et al. Clinicopathologic Characteristics of Young Patients with Oral Squamous Cell Carcinoma. Head Neck Pathol. 2021;15:1099-108.

https://doi.org/10.1007/s12105-021-01320-w

PMid:33797696 PMCid:PMC8633158

11. Roza ALOC, Kowalski LP, William WN Jr, de Castro G Jr, Chaves ALF, Araújo ALD, et al. Latin American Cooperative Oncology Group-Brazilian Group of Head and Neck Cancer. Oral leukoplakia and erythroplakia in young patients: a systematic review. Oral Surg Oral Med Oral Pathol Oral Radiol. 2021;131:73-84.

https://doi.org/10.1016/j.oooo.2020.09.002

PMid:33187936 

12. Napier SS, Speight PM. Natural history of potentially malignant oral lesions and conditions: an overview of the literature. J Oral Pathol Med. 2008;37:1-10.

https://doi.org/10.1111/j.1600-0714.2007.00579.x

PMid:18154571 

13. Zhang L, Cheung KJ Jr, Lam WL, Cheng X, Poh C, Priddy R, et al. Increased genetic damage in oral leukoplakia from high risk sites: potential impact on staging and clinical management. Cancer. 2001;91:2148-55.

https://doi.org/10.1002/1097-0142(20010601)91:11<2148::AID-CNCR1243>3.0.CO;2-G

PMid:11391596 

14. Mello FW, Miguel AFP, Dutra KL, Porporatti AL, Warnakulasuriya S, Guerra ENS, Rivero ERC. Prevalence of oral potentially malignant disorders: A systematic review and meta-analysis. J Oral Pathol Med. 2018;47:633-40.

https://doi.org/10.1111/jop.12726

PMid:29738071 

15. Sturgis EM, Cinciripini PM. Trends in head and neck cancer incidence in relation to smoking prevalence: an emerging epidemic of human papillomavirus-associated cancers?. Cancer. 2007;110:1429-35.

https://doi.org/10.1002/cncr.22963

PMid:17724670 

16. Jaber MA, Porter SR, Speight P, Eveson JW, Scully C. Oral epithelial dysplasia: clinical characteristics of western European residents. Oral Oncol. 2003;39:589-96.

https://doi.org/10.1016/S1368-8375(03)00045-9

PMid:12798402 

17. Speight PM, Khurram SA, Kujan O. Oral potentially malignant disorders: risk of progression to malignancy. Oral Surg Oral Med Oral Pathol Oral Radiol. 2018;125:612-27.

https://doi.org/10.1016/j.oooo.2017.12.011

PMid:29396319 

18. Warnakulasuriya S. Global epidemiology of oral and oropharyngeal cancer. Oral Oncol. 2009;45:309-16.

https://doi.org/10.1016/j.oraloncology.2008.06.002

PMid:18804401 

19. Ilhan B, Epstein JB, Guneri P. Potentially premalignant disorder/lesion versus potentially premalignant patient: Relevance in clinical care. Oral Oncol. 2019;92:57-58.

https://doi.org/10.1016/j.oraloncology.2019.03.009

PMid:31010624 

20. Huber JC, Schneeberger C, Tempfer CB. Genetic modelling of the estrogen metabolism as a risk factor of hormone-dependent disorders. Maturitas. 2002;42:1-12.

https://doi.org/10.1016/S0378-5122(02)00021-X

PMid:12020974 

21. Suba Z. Gender-related hormonal risk factors for oral cancer. Pathol Oncol Res. 2007;13:195-202.

https://doi.org/10.1007/BF02893499

PMid:17922048 

22. Warnakulasuriya S, Ariyawardana A. Malignant transformation of oral leukoplakia: a systematic review of observational studies. J Oral Pathol Med. 2016;45:155-66.

https://doi.org/10.1111/jop.12339

PMid:26189354